Loading organizations...
§ Private Profile · Or Yehuda, Tel Aviv, Israel
Medtech develops minimally invasive transcatheter LAA exclusion for atrial fibrillation stroke prevention, no implant.
Append Medical is an Or Yehuda, Israel-based clinical-stage medical device company developing a transcatheter system for minimally invasive left atrial appendage exclusion to reduce stroke risk in patients with atrial fibrillation. The startup's proprietary technology completely seals the appendage using a specialized tissue manipulation procedure that leaves no metal implants behind in the patient's heart. Operating as a pre-revenue enterprise with fewer than fifty employees, the firm has secured venture capital financing including a $7.4 million Series A round in 2021 and an initial $4.35 million extended Series A closing in 2022. The company is backed by corporate and institutional investors such as Boston Scientific, MEDX Xelerator, Intellectual Ventures, and Shoni Health Ventures. Append Medical was originally founded in 2017 by Zachi Berger, Ziv Bahloul, and Leonid Sternik, and recently appointed Shlomi Nachman as Chairman.
Append Medical has raised $4.3M across 1 funding round.
Append Medical has raised $4.3M in total across 1 funding round.
Append Medical has raised $4.3M across 1 funding round. Most recently, it raised $4.3M Series A Extension in July 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 6, 2023 | $4.3M Series A Plus | — | Alive Israel Healthtech Fund, Shoni TOP Ventures | Announced |
Append Medical has raised $4.3M in total across 1 funding round.
Append Medical's investors include ALIVE Israel HealthTech Fund, Shoni Top Ventures.